Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Smits

Showing results (181-190 of 295) with videos related to

Pageof 30
Sort By:
Journal of the American College of Cardiology|June 13, 2015
Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-AnalysisTullio Palmerini, Umberto Benedetto, Giuseppe Biondi-Zoccai, et al.
Circulation|March 3, 2004
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) studyPedro A Lemos, Angela Hoye, Dick Goedhart, et al.
The American Journal of Cardiology|May 12, 2004
Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patientsEvelyn Regar, Pedro A Lemos, Francesco Saia, et al.
Circulation|February 5, 2003
TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulationKengo Tanabe, Patrick W Serruys, Eberhard Grube, et al.
The American Journal of Cardiology|June 29, 2004
Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameterAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Journal of the American College of Cardiology|February 21, 2004
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarctionPedro A Lemos, Francesco Saia, Sjoerd H Hofma, et al.
Journal of Cardiology|October 12, 2020
Patient perspectives on left main stem revascularization strategies, the OPINION-2 studyRutger-Jan Nuis, Adeel Jadoon, Bas M van Dalen, et al.
JACC. Cardiovascular Interventions|March 9, 2025
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Eclinicalmedicine|December 18, 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with <i>de novo</i> coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 3, 2019
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB TrialChun Chin Chang, Yoshinobu Onuma, Stephan Achenbach, et al.
Pageof 30

Showing results (181-190 of 295) with videos related to

Sort By:
Pageof 30
Journal of the American College of Cardiology|June 13, 2015
Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-AnalysisTullio Palmerini, Umberto Benedetto, Giuseppe Biondi-Zoccai, et al.
Circulation|March 3, 2004
Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) studyPedro A Lemos, Angela Hoye, Dick Goedhart, et al.
The American Journal of Cardiology|May 12, 2004
Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patientsEvelyn Regar, Pedro A Lemos, Francesco Saia, et al.
Circulation|February 5, 2003
TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulationKengo Tanabe, Patrick W Serruys, Eberhard Grube, et al.
The American Journal of Cardiology|June 29, 2004
Effectiveness of sirolimus-Eluting stent implantation for coronary narrowings <50% in diameterAngela Hoye, Pedro A Lemos, Chourmouzios A Arampatzis, et al.
Journal of the American College of Cardiology|February 21, 2004
Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarctionPedro A Lemos, Francesco Saia, Sjoerd H Hofma, et al.
Journal of Cardiology|October 12, 2020
Patient perspectives on left main stem revascularization strategies, the OPINION-2 studyRutger-Jan Nuis, Adeel Jadoon, Bas M van Dalen, et al.
JACC. Cardiovascular Interventions|March 9, 2025
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Eclinicalmedicine|December 18, 2023
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with <i>de novo</i> coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCTShigeru Saito, Johan Bennett, Holger M Nef, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 3, 2019
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB TrialChun Chin Chang, Yoshinobu Onuma, Stephan Achenbach, et al.
Pageof 30